KBW Raises EPS From $15.99 To $16.04 And Reiterate Overweight Rating On CME Group

In a recent report, Keefe, Bruyette & Woods has raised EPS estimates from $15.99 to $16.04 and reiterated an overweight rating on CME Group CME after CME announced a $750 mln buyback on Monday. In the report, KBW said, "The growth focus is organic, prioritizing cross selling and extending liquidity past a US trading house with partnerships helping this process." The price target on CME remains at $337.00. CME closed yesterday at $295.01.